Palladium

MaxLinear Partners with MACOM and II-VI to Showcase 100Gbps Per Lane Multi-Mode Links at OFC

Retrieved on: 
Tuesday, March 8, 2022

This week at OFC 2022, MaxLinear (NASDAQ: MXL), in cooperation with MACOM and II-VI, will be showcasing 100G/lane multi-mode links targeted for 800G optical modules.

Key Points: 
  • This week at OFC 2022, MaxLinear (NASDAQ: MXL), in cooperation with MACOM and II-VI, will be showcasing 100G/lane multi-mode links targeted for 800G optical modules.
  • These links incorporate the MaxLinear Keystone 5nm 800G DSP, MACOM 100G/lane TIAs and VCSEL drivers and II-VI latest 850nm VCSELs and photodetectors.
  • Bringing these products together provides the capability to support long multi-mode links for cloud and data center applications.
  • "We are excited to demonstrate the use of our Keystone 800G DSP for multi-mode links," said Drew Guckenberger, Vice President of Optical Interconnect at MaxLinear.

Sixty North Gold Engages Countryman Investments Limited to Advise Management and the Board in Financing and Marketing Opportunities, and Announces Stock Option Grants

Retrieved on: 
Monday, March 7, 2022

Countryman is an investment and advisory services company that has provided such services to public and private companies for over 40 years, including resource companies.

Key Points: 
  • Countryman is an investment and advisory services company that has provided such services to public and private companies for over 40 years, including resource companies.
  • In 2010, the company merged with Golden Goose Resources and was renamed Prodigy Gold Incorporated to better reflect their operations.
  • Countryman continues to be an enthusiastic investor in the mining and exploration sector, lending its support and expertise to a number of public companies.
  • The Company is focused on bringing its Mon Mine in the Yellowknife Gold Belt, NWT Canada back into production.

Serabi Gold Reports Mineral Reserves and Resources for Palito Complex as at 31 December 2021

Retrieved on: 
Monday, March 7, 2022

Proven underground Mineral Reserves are reported within the Measured classification domain, and Probable underground Mineral Reserves are reported within the Indicated classification domain.

Key Points: 
  • Proven underground Mineral Reserves are reported within the Measured classification domain, and Probable underground Mineral Reserves are reported within the Indicated classification domain.
  • Serabi is the operator and owns 100% of the Palito and Sao Chico Mines such that gross and net attributable mineral reserves and resources are the same.
  • Proven and Probable Mineral Reserves at the Palito Complex total 67,344 ounces of gold as at 31 December 2021, an increase on the December 2020 MRE of 5,623 ounces.
  • Mineral resources are not mineral reserves and do not have demonstrated economic viability but do have reasonable prospect for economic extraction.

A New Report from IDC Looks at the Initial Impact of the Russia-Ukraine War on Global ICT Markets

Retrieved on: 
Monday, March 7, 2022

A new International Data Corporation ( IDC ) report provides an initial assessment of how the crisis will affect ICT spending* and technology markets worldwide.

Key Points: 
  • A new International Data Corporation ( IDC ) report provides an initial assessment of how the crisis will affect ICT spending* and technology markets worldwide.
  • "The evolving geopolitical scenario will undoubtedly affect global ICT demand in the coming months and years," said Andrea Siviero , associate research director, European Customer Insights & Analysis .
  • While IDC expects a steep decline and slow recovery for ICT spending in Russia and Ukraine, the global impact of this decline will be somewhat limited.
  • Combined the two countries only account for 5.5% of all ICT spending in Europe and 1% worldwide.

Canada Silver Cobalt Reports Positive Battery Metals Assay Results from Its Massive Sulphide Discovery at Graal in Northern Quebec

Retrieved on: 
Thursday, March 3, 2022

Assay results confirm the existence of strong nickel, copper and cobalt mineralization in addition to discovering low grade platinum and palladium.

Key Points: 
  • The 6,113-hectare Graal property is one of 14 properties recently acquired in northern Quebec covering 31,201 hectares that are prospective for EV battery metals such as nickel, copper, and cobalt.
  • Blank and standards were included in the sample batch and their values allows the public disclosure of the assay results.
  • This discovery has the highest silver resource grade in the world, with recent drill intercepts of up to 89,853 grams/tonne silver (2,621 oz/ton Ag).
  • Please refer to Canada Silver Cobalt Works Press Release May 28, 2020, for the resource estimate.

Aether Catalyst Solutions, Inc. Ships Catalyst for In-Vehicle Testing with Fleetco

Retrieved on: 
Monday, February 28, 2022

The Aether team examined its entire process and broke it down step by step to re-optimize for production of full-scale parts.

Key Points: 
  • The Aether team examined its entire process and broke it down step by step to re-optimize for production of full-scale parts.
  • This allowed Aether to make decisions about the catalyst composition that are intended to address our typical weaknesses.
  • Taylor Procyk, COO of Aether comments, "The team at Fleetco has been extremely supportive throughout the build of our evaluation catalyst.
  • We now look forward to getting our baseline results from Fleetco and iterating our way to a commercial catalyst."

Aquis Stock Exchange: Updated Announcement of Application for Admission to the AQSE Growth Market

Retrieved on: 
Saturday, March 5, 2022

The metals extracted for recycling include gold, platinum, rhodium and palladium.

Key Points: 
  • The metals extracted for recycling include gold, platinum, rhodium and palladium.
  • The company uses a network of partners to source, acquire, store, and process material and once the waste precious metal is ready it is supplied to refineries, in countries such as Japan, for reconstitution and resupply in to the global supply chain.
  • NAME OF AQSE CORPORATE ADVISER:
    NUMBER, CLASS AND PAR VALUE OF SECURITIES TO BE ADMITTED:
    SHAREHOLDERS HOLDING MORE THAN FIVE PER CENT OF THE APPLICANT'S SHARE CAPITAL OR VOTING RIGHTS PRE- AND POST-ADMISSION:
    Li Ting Yang is the spouse of Peter Lai.
  • Lionel Lai is their adult son.

Coherus and Junshi Biosciences Announce Positive Results from Phase 3 Esophageal Cancer Study of Toripalimab Published in Cancer Cell

Retrieved on: 
Friday, March 4, 2022

REDWOOD CITY, Calif., and SHANGHAI, China, March 04, 2022 (GLOBE NEWSWIRE) -- Coherus BioSciences, Inc. (“Coherus”, Nasdaq: CHRS) and Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) today announced the online publication in Cancer Cell of Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): a multi-center randomized phase 3 trial. The manuscript publication was accompanied by a Cancer Cell editorial preview entitled Jupiter-06 establishes immune checkpoint inhibitors as essential first-line drugs for the treatment of advanced esophageal squamous cell carcinoma.

Key Points: 
  • The study results were first presented in a mini-oral session during the European Society for Medical Oncology (ESMO) Congress 2021.
  • The robust results from the JUPITER-06 study add to the emerging body of clinical evidence of toripalimabs clinical activity across multiple tumor types.
  • A statistically significant improvement in OS was detected in the toripalimab arm:
    Median OS in the toripalimab and placebo arms were 17 vs. 11 months respectively.
  • Coherus and Junshi Biosciences plan to file additional toripalimab BLAs with the FDA over the next three years for multiple other cancer types.

Junshi Biosciences and Coherus Announce Positive Results from Phase 3 Esophageal Cancer Study of Toripalimab Published in Cancer Cell

Retrieved on: 
Friday, March 4, 2022

SHANGHAI, China and REDWOOD CITY, Calif., March 04, 2022 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180) and Coherus BioSciences, Inc. today announced the online publication in Cancer Cell of Toripalimab plus chemotherapy in treatment-naïve, advanced esophageal squamous cell carcinoma (JUPITER-06): a multi-center randomized phase 3 trial. The manuscript publication was accompanied by a Cancer Cell editorial preview entitled Jupiter-06 establishes immune checkpoint inhibitors as essential first-line drugs for the treatment of advanced esophageal squamous cell carcinoma.

Key Points: 
  • The study results were first presented in a mini-oral session during the European Society for Medical Oncology (ESMO) Congress 2021.
  • The robust results from the JUPITER-06 study add to the emerging body of clinical evidence of toripalimabs clinical activity across multiple tumor types.
  • A statistically significant improvement in OS was detected in the toripalimab arm:
    Median OS in the toripalimab and placebo arms were 17 vs. 11 months respectively.
  • Coherus and Junshi Biosciences plan to file additional toripalimab BLAs with the FDA over the next three years for multiple other cancer types.

UPDATED: PDS Recognizes K&K Pharmacy in its Annual Showcase of Success Series for Implementing Innovative Strategies During the COVID-19 Pandemic

Retrieved on: 
Friday, March 4, 2022

Lake Worth, FL, March 03, 2022 (GLOBE NEWSWIRE) -- Pharmacy Development Services (PDS) recognized K&K Pharmacy, in Muleshoe, TX, during its annual Super-Conference, Showcase of Success series, for overcoming adversity throughout the pandemic.

Key Points: 
  • Lake Worth, FL, March 03, 2022 (GLOBE NEWSWIRE) -- Pharmacy Development Services (PDS) recognized K&K Pharmacy, in Muleshoe, TX, during its annual Super-Conference, Showcase of Success series, for overcoming adversity throughout the pandemic.
  • COVID-19 brought a drop in patient volume for K&K Pharmacy.
  • She was recognized by the Texas Educational Support Staff Association and asked to bring her mobile unit to its conferences.
  • The most important thing for me is that PDS keeps me out of the pharmacy so I can work on my business.